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BACKGROUND: Epidural block are often used for analgesia after open nephrectomy surgery. 
Subcostal anterior quadratus lumborum block may be an alternative. We therefore tested the 
hypothesis that the continuous subcostal anterior quadratus lumborum block is noninferior to 
epidural block for analgesia in patients having open partial nephrectomies.
METHODS: Adults having open partial nephrectomies were randomly allocated to epidural or 
unilateral subcostal anterior quadratus lumborum block. The joint primary outcomes were opi-
oid consumption measured in morphine equivalents and pain measured on a numeric rating 
scale (0–10) from postanesthesia care unit (PACU) until 72 hours after surgery. The noninferior-
ity deltas were 30% for opioid consumption and 1 point on a 0–10 scale for pain. Secondary 
outcomes included patient global assessment of pain management on the third postoperative 
day, the number of antiemetic medication doses through the third postoperative day, duration of 
PACU stay, and postoperative duration of hospitalization.
RESULTS: Twenty-six patients were randomized to anterior quadratus lumborum block and 29 
to epidural analgesia. Neither pain scores nor opioid consumption in the quadratus lumborum 
patients were noninferior to epidural analgesia. At 72 hours, mean ± standard deviation pain 
scores in subcoastal anterior quadratus lumborum block and epidural group were 4.7 ± 1.8 
and 4.1 ± 1.7, with an estimated difference in pain scores of 0.62 (95% confidence interval 
[CI], 0.74-1.99; noninferiority P = .21). The median [Q1, Q3] opioid consumption was more 
than doubled in quadratus lumborum patients at 70 mg [43, 125] versus 30 mg [18, 75] in the 
epidural group with an estimated ratio of geometric means of 1.69 (95% CI, 0.66-4.33; nonin-
feriority P = .80). Patient global assessment and duration of PACU and hospital stays did not 
differ significantly in the 2 groups.
CONCLUSIONS: We were unable to show that subcostal anterior quadratus lumborum block are 
noninferior to epidural analgesia in terms of pain scores and opioid consumption for open par-
tial nephrectomies. Effectiveness of novel blocks should be rigorously tested in specific surgical 
setting before widespread adoption. (Anesth Analg 2021;132:1138–45)
KEY POINTS
• Question: Is continuous subcostal anterior quadratus lumborum block noninferior to epidural 
block in terms of pain score and opioid consumption among patients undergoing open partial 
nephrectomy?
• Findings: Neither pain scores nor opioid consumption in the subcostal anterior quadratus 
lumborum group were noninferior to epidural analgesia.
• Meaning: We were unable to show that subcostal anterior quadratus lumborum block are 
noninferior to epidural analgesia for reducing pain scores and opioid consumption for open 
partial nephrectomies.
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GLOSSARY
ASA = American Society of Anesthesiologists; BMI = body mass index; CABG = coronary artery 
bypass graft; CI = confidence interval; CONSORT = Consolidated Standards of Reporting Trials; Nmiss =  
the number of missing; NI = noninferiority; NI-P = noninferiority P value; ORSDS = Opioid-Related 
Symptom Distress Scale; PACU = postanesthesia care unit; POD = postoperative day; QL = quadra-
tus lumborum; QoR = quality of recovery; SD = standard deviation; TWA = time-weighted average
Open nephrectomies cause substantial postop-erative pain. Thoracic epidural analgesia is generally considered the best analgesia for 
abdominal wall surgeries, but use in renal surgery 
is limited due to hypotension and because it pre-
cludes use of postoperative anticoagulants which are 
often indicated.1,2 Analgesic management in patients 
recovering from renal surgery therefore remains chal-
lenging and often depends on opioids despite their 
well-known limitations and risks.3
Recently developed truncal interfascial blocks such 
as the quadratus lumborum (QL) block may reduce 
pain after open renal surgery.4,5 Compared to thoracic 
epidural analgesia, QL blocks do not cause a gener-
alized lower body sympathectomy, and thus do not 
promote hypotension. Furthermore, the block is rela-
tively safe even when patients are anticoagulated.5
Various local anesthetic injection sites have been 
described for QL blocks, and the injection site deter-
mines which dermatomes are covered.6 But injecting 
local anesthetic anterior to QL muscle presumably 
allows drug to spread into the thoracic paravertebral 
space, thereby blocking the somatic and thoracic sym-
pathetic trunk of lower thoracic segments.6–9 Using a 
subcostal anterior approach appears to extend derma-
tomal coverage based on a cadaver study.10 In a pilot 
series of 22 patients, we observed T6-L2 dermatomal 
coverage that should be suitable for subcostal nephrec-
tomy incisions.9 However, it remains unknown 
whether subcostal anterior QL block provide analgesia 
comparable to thoracic epidural block. We therefore 
tested the hypothesis that subcostal anterior QL block 
with a continuous catheter are noninferior to epidural 
analgesia on pain control and opioid consumption in 
patients having open partial nephrectomy.
METHODS
The trial was approved by the Cleveland Clinic 
Institutional Review Board (IRB #15-1291). The study 
was registered at Clinical Trials.gov (NCT03110081; 
principal investigator: Hesham Elsharkawy; date: 
December 22, 2016) before the first patient was 
enrolled. This study followed good clinical practice 
quality standards and ethical guidelines described 
by the Declaration of Helsinki.11 Written informed 
consent was obtained from all participating patients. 
This article adheres to the applicable Consolidated 
Standards of Reporting Trials (CONSORT) guidelines.
We included adults aged ≥18 years, who were 
scheduled for elective open unilateral partial nephrec-
tomy surgery at Cleveland Clinic Main Campus and 
Fairview Hospital. Patients were excluded if they had 
intolerance or allergy to opioids, were pregnant, had 
contraindications to epidural analgesia or QL block, or 
had chronic pain characterized by opioid use for >30 
consecutive days within the 3 preoperative months at 
a dose equivalent to at least 15 mg of morphine.12
Patients were randomized 1:1, stratified by trial 
site, to either a unilateral subcostal anterior QL cath-
eter or an epidural catheter. Randomization was 
based on computer-generated random allocation 
sequences with random block sizes. Allocations were 
maintained on a secure website that was accessed just 
before performance of the procedure. Allocation was 
thus concealed to the extent practical.
Both epidural blocks and subcostal anterior QL 
blocks were performed by faculty anesthesiologists 
who had served on the acute pain management service 
for at least 4 years and had performed at least 40 QL 
blocks. Blocks were deemed failures if the expected 
dermatomal coverage was not apparent. Catheters 
were then repositioned or removed and reinserted.
We used a previously described approach to sub-
costal anterior QL block.9 In summary, the patients 
were positioned lateral decubitus. A curvilinear 
2–5 MHz ultrasound transducer (SonoSite S-Nerve, 
Bothell, WA) was positioned posteriorly below the 
12th rib in a parasagittal oblique plane at L1-2 level. 
The QL muscle was visualized and its point of inser-
tion on the 12th rib identified. An 18-gauge Tuohy 
needle was advanced in the caudal-to-cranial direc-
tion between QL muscle and the psoas major muscle 
until a click could often be felt as the needle tip pen-
etrated the anterior investing fascia of the QL muscle. 
After a negative aspiration, 20 mL of 0.25% bupiva-
caine was injected through the needle to help confirm 
the final needle tip position, anterior to the QL muscle 
at close proximity to the 12th rib.
Thereafter, a 19-gauge peripheral nerve catheter 
(InfiltraLong Catheter, PAJUNK, Geisingen, Germany) 
was advanced 2–4 cm past the needle tip. Five milliliters 
of bupivacaine 0.25% was injected through the catheter 
to ensure catheter location. The catheter was tunneled 
medially then secured by transparent dressing and an 
ambulatory electronic infusion pump (Moog Curlin 
Infusion Pump, Salt Lake City, UT) was attached to the 
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catheter. An infusion of ropivacaine 0.2% was started 
towards the end of surgery in the operating room at 
a rate of 8 mL/h. Postoperatively, a continuous infu-
sion of ropivacaine 0.2% was given through the cath-
eter at a basal rate of 8 mL/h with patient-controlled, 
on-demand boluses of 6 mL allowed every 30 minutes. 
The infusion continued for at least 48 hours, and longer 
if deemed necessary by the acute pain team.
Patients assigned to epidural analgesia had mid-
thoracic catheters inserted preoperatively at T7-8, 
guided by anatomical surface landmarks. A 17-gauge 
Tuohy needle was inserted either midline or parame-
dian, and the epidural space was identified by loss-
of-resistance to saline. The catheter was threaded 
through the needle and advanced 2–4 cm past the 
needle tip. The catheter position was tested by inject-
ing 3 mL of a mixture of lidocaine 1.5% and epineph-
rine 1:200,000 through the catheter. The epidural 
catheter was secured by transparent dressing and an 
ambulatory electronic infusion pump was attached to 
the catheter hub.
An infusion of bupivacaine 0.1% was started 
towards the end of surgery in the operating room at 
an infusion rate of 5 mL/h, and continuously admin-
istered for at least 48 hours and longer if deemed 
necessary by the acute pain team. Patient-controlled 
epidural boluses of 6 mL every 30 minutes were per-
mitted. Local anesthetic was infused through both the 
peripheral nerve catheter and epidural catheter at the 
end of the surgery and in the postoperative period 
via an ambulatory electronic infusion pump (Moog 
Curlin Infusion Pump).
Clinicians performing the blocks and patients 
were not blinded, but investigators evaluating the 
outcomes were blinded to randomization. Bandages 
were positioned over the catheter and the infusion 
pump such that it was not obvious which block 
patients were assigned to. Similarly, control panels for 
the infusion pumps and the drug bags were covered 
to blind investigators evaluating outcomes.
All patients received general volatile anesthesia for 
surgery per institutional routine. Only fentanyl was 
permitted intraoperatively. Wound infiltration with 
local anesthetics and nonsteroidal anti-inflammatory 
medications were not permitted. In the postanesthe-
sia care unit (PACU), patients were given intravenous 
boluses of opioids as needed according to the surgical 
and pain teams.
Patients in both groups received an intravenous 
patient-controlled analgesia system for rescue analgesia 
if needed. The intravenous patient-controlled analgesia 
system was provided with fentanyl boluses of 25 µg at 
6-minute intervals without a basal infusion. Patients 
were also given intravenous boluses of fentanyl 
(25–50 µg) or hydromorphone (0.2–0.4 mg) for break-
through pain if needed. Patients were given 1000 mg of 
intravenous acetaminophen in the PACU, followed by 
1000 g oral acetaminophen 3 times daily for 48 hours.
Measurements
Baseline characteristics, including age, sex, race, 
and body mass index were retrieved from electronic 
medical records. Medical history, American Society 
of Anesthesiologists physical status, duration of 
surgery, and smoking status were recorded by the 
investigators.
The primary outcomes were opioid consumption 
and pain scores in the first 72 postoperative hours. 
Total opioid consumption was estimated as intrave-
nous morphine equivalents.13 Pain scores, based on 
nursing assessments on a numeric pain rating scale 
(0–10, with 10 being worst) were recorded at 4-hour 
intervals and summarized as time-weighted average 
value by trapezoidal method.
We recorded the quality of recovery (QoR)-15 score 
and patient global assessment of pain management on 
the third postoperative day, along with the total num-
ber of antiemetic medication doses through the third 
postoperative day. Duration in the PACU stay and of 
postoperative hospitalization were also recorded.14–17
Safety and quality outcomes included 2 compo-
nents: (1) adverse events related to opioid use mea-
sured with the Opioid-Related Symptom Distress 
Scale18 and (2) a collapsed composite of postoperative 
oxygen administration, naloxone administration, and 
discontinuation of the local anesthetic infusion within 
72 hours due to hypotension or weakness interfering 
with physical therapy or mobility.
On an exploratory basis, a blinded investigator 
assessed the dermatomal sensory level ipsilateral to 
the surgical incision using ice on postoperative days 
1–3. We also quantified ward hypotensive episodes 
through discharge, defined by mean arterial pres-
sure <65 mm Hg, as measured by nurses at 4-hour 
intervals.
Statistical Analysis
We assessed balance of the randomized groups on 
baseline and procedural characteristics using abso-
lute standardized difference, defined as the absolute 
difference in mean values, mean ranks, or propor-
tions divided by the pooled standard deviation (SD). 
Baseline variables with absolute standardized 










 were considered 
imbalanced.
In the primary analysis, we assessed noninferiority 
of QL catheters to epidural analgesia on pain scores 
and total intravenous morphine equivalent doses of 
rescue opioid (after a logarithmic transformation) 
until the third postoperative day with 1-tailed non-
inferiority t tests. Noninferiority was tested using the 
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confidence interval (CI) method, defined as not >30% 
higher in opioid consumption and not >1 point worse 
in pain score. Specifically, noninferiority would be 
claimed if the upper limit of the 95% 2-sided (corre-
sponds to α of .025 on upper tail) CI for the ratio of 
geometric mean values of total opioid consumption 
was less than the noninferiority delta of 1.3, and for 
the difference in mean values of pain score was less 
than the noninferiority delta of 1 point. P values were 
obtained from a 1-tailed t test using a test statistic 







, where β1  is the estimated treat-
ment effect, SE
1β
 is the standard error of the treatment 
effect, and δ is the noninferiority delta. The overall 
significance level for noninferiority is .025 and the sig-
nificance criterion for each test is also .025. In this joint 
hypothesis testing scenario, no adjustment for tests on 
2 outcomes was needed because both outcomes are 
required to be significant to claim that QL is noninfe-
rior (ie, this is an intersection-union test).19
Analyses were modified intent-to-treat and thus 
included all randomized patients who received some 
amount of study intervention. We planned 3 interim 
analyses to assess efficacy and futility of the primary 
outcome at every 25% of the planned enrollment using 
a group sequential design with a gamma-spending 
function (γ = −4 for efficacy and −2 for futility) and 
nonbinding futility boundaries. The overall signifi-
cance level was maintained at .025 across the interim 
monitoring. At the secondary interim, the P value 
boundaries were P < .0024 for efficacy and P ≥ .36 for 
futility for the primary outcomes. CIs for the primary 
outcomes are thus estimated using the z-statistic cor-
responding to the significance criterion at the second 
interim, making them 99.76% CIs. However, we refer 
to them as “95% CI” throughout since the 1-sided 
alpha level for the study was .025.
We compared the randomized groups for each sec-
ondary outcome using appropriate 2-tailed tests for 
superiority. Specifically, patient global assessment 
was compared using Wilcoxon rank sum tests. Any 
antiemetic medications and any episodes of hypoten-
sion were assessed using logistic regression. Length of 
hospital stay and PACU stay was assessed using linear 
regression. The significance level for the set of second-
ary outcomes is preserved at .05 overall using a criterion 
of P < .05/5 = .01 for each test (applying a Bonferroni 
correction for multiple testing of the 5 secondary out-
comes). We used SAS version 9.4 for the analyses.
Sample Size and Power
Sample size was based on being able to detect nonin-
feriority on both total opioid consumption and pain 
score in the first 72 hours with about 85% overall 
power at the overall .025 significance level. Based on 
pilot data, we assume that QL block provides equal 
efficacy compared to epidural; time-weighted aver-
age pain scores have a mean of about 4 with a SD of 
1.5; the opioid consumption with a coefficient of vari-
ation (SD/mean) of 0.45. For a single-analysis study, 
we would need about 100 patients to detect noninfe-
riority for opioid consumption at the .025 significance 
level, assuming noninferiority delta of 1.3 in ratio of 
geometric means (ie, 30% increase in opioid consump-
tion). At the same time, a total of 100 patients would 
give over 90% power to detect noninferiority in pain 
score with a delta of 1 point.
RESULTS
We enrolled patients from May 2017 to February 2019 
at the Cleveland Clinic Main Campus and Cleveland 
Clinic Fairview Hospital. The second interim analysis 
was conducted after 50% of the planned patients were 
enrolled. Because futility boundaries (P ≥ .36) were 
crossed at that time, the study was concluded per pro-
tocol after enrollment of 55 patients. No patient with-
drew from this study, thus we included all of them in 
the analyses. A total of 26 patients were randomized 
to QL blocks and 29 to epidural analgesia (Figure 1). 
The absolute standardized difference of all potentially 
confounding baseline and procedural characteristics 
were within 0.53, so we did not adjust for any con-
founders in all analyses (Table  1). Dermatomal sen-
sory block levels are shown in Figure 2.
Time-weighted average pain scores and total opi-
oid consumption in the first 72 hours after surgery 
are summarized by treatment group in Table  2 and 
Figure 3. Mean ± SD pain scores in subcoastal anterior 
QL block and epidural group were 4.7 ± 1.8 and 4.1 ± 
1.7, with an estimated difference in pain scores of 0.62 
(95% CI, 0.74-1.99; noninferiority P = .21). The median 
[Q1, Q3] opioid consumption was more than doubled 
in QL patients at 70 mg [43, 125] versus 30 mg [18, 75] 
in the epidural group with an estimated ratio of geo-
metric means of 1.69 (95% CI, 0.66-4.33; noninferiority 
P = .80).
The secondary outcomes are summarized in 
Table 3. Length of PACU stay, length of hospital stays, 
QoR-15 score, the incidence of postoperative anti-
emetic medication, and patient global assessment on 
postoperative day 3 did not differ significantly in the 
QL and epidural groups. Safety and quality outcomes 
were summarized in Table 3. There were no clinically 
meaningful differences between the groups.
DISCUSSION
The trial was stopped per protocol at a planned 
interim analysis on the basis of futility. Specifically, 
the results were inconsistent with our hypothesis that 
subcostal QL block are noninferior to epidural anal-
gesia on pain and opioid consumption. No signifi-
cant difference in pain scores were noted with each 
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approach as is typical in such trials because patients 
use patient-controlled opioids to suitably block sur-
gical pain. In contrast, patients randomized to QL 
blocks used more than twice as much opioid as those 
given epidural analgesia.
Our results contrast with 2 similar trials compar-
ing QL block and epidural analgesia for nephrectomy 
surgery.20,21 However, both restricted enrollment to 
patients having laparoscopic procedures whereas all 
our patients had open surgery, which is more painful. 
Furthermore, open nephrectomy incisions involve 
anterolateral abdominal wall innervation by T6-T12 
thoracolumbar spinal nerves.22 The pain originating 
from kidney reaches the lower thoracic spinal cord via 
celiac and renal plexus, greater and lesser splanchnic 
nerves, and sympathetic and parasympathetic trunks 
with nerve root innervation from T4-L1.23,24 Adequate 
visceral coverage therefore requires blocks reaching 
to T4. Although cadaver studies indicate that injected 
contrast can spread cranially through the thoracic 
paravertebral space to T4, the actual extent of sensory 
dermatomal coverage in our QL patients was less and 
inconsistent, ranging from T6 to L2.8,10 In contrast, 
epidural blocks were more consistent and had wider 
dermatomal coverage, ranging from T4 to L2.
An additional factor is that open nephrectomy inci-
sions often extend to the midline, an area better cov-
ered by the bilateral analgesia of epidural block.24 And 
finally, visceral postoperative pain may also be better 
covered by epidural block. There are thus various rea-
sons that epidural analgesia is preferable to QL block 
for open nephrectomy surgery—although previous 
work suggests that the block are suitable for laparo-
scopic nephrectomies. There was no significant differ-
ence in PACU duration and overall length of hospital 
stay in patients randomized to QL or epidural blocks, 
presumably because no evidence for a difference in 
pain scores was observed.
Our trial did not demonstrate reduced post-
operative nausea and vomiting in the QL group. 
Midthoracic epidural effectively blocks sympathetic 
Figure 1. Flow chart. QL indicates 
quadratus lumborum.








Demographics    
 Age (y) 63 ± 10 65 ± 12 −0.17
 Sex (female versus male) 14 (54) 9 (31) 0.47
 BMI (kg/m2) 33 ± 8 33 ± 7 0.02
 Race   0.05
  White 22 (85) 25 (86)  
  Black 3 (12) 3 (10)  
  Other 1 (4) 1 (3)  
 ASA physical status   0.26
  II 2 (8) 1 (3)  
  III 22 (85) 24 (83)  
  IV 2 (8) 4 (14)  
Medical history    
 Obstructive sleep apnea 6 (23) 4 (14) 0.24
 Diabetes mellitus 7 (27) 5 (17) 0.24
 Myocardial infarction 5 (19) 2 (7) 0.37
 Ischemic heart disease  
(angina/stent/CABG)
2 (8) 6 (21) −0.38
 Chronic pain requiring opioids 0 (0) 2 (7) −0.38
 Current smoker 2 (8) 5 (17) −0.29
 Cancer 17 (65) 13 (45) 0.42
 Duration of surgery (h) 5.3 ± 1.3 5.5 ± 0.9 −0.26
 Length of PACU stay (h) 2.2 ± 1.0 2.2 ± 0.9 −0.01
 Length of hospital stay (d) 5.0 ± 1.3 5.3 ± 1.4 −0.15
Summary statistics are presented as mean scores ± standard deviations 
or N (column %).
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass 
index; CABG, coronary artery bypass graft; PACU, postanesthesia care unit; 
QL, quadratus lumborum.
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Figure 2. Dermatome coverage 
on PODs 1–3. PODs indicates 
postoperative days; QL, quadra-
tus lumborum.
Table 2. Primary Outcome Analysis: Comparison Between QL Block and Epidural Analgesia on Pain Score 





(N = 29) NI delta Effect size (95% CI)a NI-Pb
Pain score, mean ± SDc   Difference in mean values (QL − epidural)  
4.7 ± 1.8 4.1 ± 1.7 1 0.62 (−0.74 to 1.99) .21
Opioid consumption in mg,  
median [Q1, Q3]d
  Ratio of geometric mean values (QL/epidural)  
70 [43, 125] 30 [18, 75] 1.3 1.69 (0.66-4.33) .80
Abbreviations: CI, confidence interval; NI, noninferiority; NI-P, noninferiority P value; PACU, postanesthesia care unit; QL, quadratus lumborum block; SD, standard 
deviation.
a95% CI was adjusted for sequential design. We would claim NI if upper limit of 95% 2-sided CI < NI delta. They are called “95% CI” here and throughout since 
the 1-sided alpha level for the study was .025, even though the actual CIs at the second interim analysis were 99.8% using the efficacy boundary of P < .0024.
bSignificant if P < .0024.
cSummary statistics of pain scores are reported as mean ± SD of time-weighted average pain during the first 72 h. Difference in time-weighted average pain 
scores was assessed in a linear regression model.
dTotal opioid consumption (milligrams as intravenous morphine equivalent) in the first 72 h after surgery was summarized as median [Q1, Q3]. Difference of opioid 
consumption between 2 groups was assessed using a linear regression model after logarithm transformation of opioid consumption.
Figure 3. Pain and opioid consumption. Left panel 
shows the TWA of pain score in the first 72 h after 
surgery. Right panel shows the cumulative opioid 
consumption as intravenous morphine equivalent 
in the first 72 h after surgery (y-axis is on log 
scale). The whiskers are the 2 lines outside the 
box that extend to the highest and lowest obser-
vations. QL indicates quadratus lumborum; TWA, 
time-weighted average.
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outflow to gastrointestinal tract (T5-T12), result-
ing in an unopposed parasympathetic tone, leading 
to gut hyperperistalsis and accompanying nausea. 
Continuous nerve blocks, on the other hand, results 
in less sympathectomy and have an opioid-sparing 
effect—thus potentially reducing postoperative nau-
sea and vomiting via both mechanisms. Nonetheless, 
nausea and vomiting were nonsignificant in our 
cohort, with the caveat that our trial was too small 
to evaluate this outcome. While the overall outcomes 
were in favor of epidural block in open nephrectomy, 
interfascial blocks such as QL block may be an alter-
native in patients where adverse effects of sympa-
thectomy such as hypotension outweigh the overall 
benefits of epidural block.
Our trial was assessor-blinded, but patients knew 
their group allocations and may have believed that 
one modality or the other was preferable, resulting 
in biased pain assessments. There is no consensus on 
the best type, volume, or concentration of local anes-
thetics for QL blocks. But it is plausible that QL blocks 
require larger volumes to spread appropriately in the 
relatively large inter-muscle plane. Results may there-
fore have differed if we injected more local anesthetic 
for the plane block. In our study, we used different 
local anesthetics and concentration in the 2 random-
ized groups; 0.2% ropivacaine (QL block) versus 
0.1% bupivacaine (epidural block), might influence 
analgesia. The comparative potency ratio of mean 
effective dose of ropivacaine and bupivacaine previ-
ously noted to be 75%.25 Other factors, importantly 
the vascularity of interfascial spaces and systemic 
absorption might influence the resulted analgesia.
In summary, we were unable to show that subcostal 
anterior QL block are noninferior to epidural analge-
sia in terms of pain score and opioid consumption. No 
evidence for a difference in pain scores was observed. 
However, patients randomized to QL block required 
more than twice as much opioid over the initial 3 post-
operative days. Nonetheless, the quality of recovery 
and hospital lengths of stay were comparable with each 
approach. The efficacy of subcostal QL block should 
be rigorously investigated in specific surgical settings 
before widespread adoption. E
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Table 3. Comparison Between QL Block and Epidural Analgesia on Secondary, Safety, and Exploratory  
Outcomes
 
QL (N = 26) Epidural (N = 29) Effect size
PNmiss Summary Nmiss Summary (99% CI)
Secondary outcomesa
 Length of PACU stay (h)b 0 2.2 ± 1.0 1 2.2 ± 0.9 0.1 (−0.6, 0.8) .81
 Length of hospital stay (d)b 0 5.0 ± 1.3 0 5.3 ± 1.4 −0.2 (−1.2, 0.7) .54
 QoR-15 scoreb 1 109 ± 19 0 102 ± 21 7.2 (−7.4, 22) .19
 Any antiemetic medicationc 1 3 (12%) 0 8 (28%) 0.4 (0.04, 2.2) .16
 Patient global assessmentd 1  1   .63
  Poor  3 (12%)  5 (18%)   
  Fair  8 (32%)  7 (25%)   
  Good  11 (44%)  8 (29%)   
  Excellent  3 (12%)  8 (29%)   
Safety and quality outcomese
Effect size
(95% CI)
 ORSDSb 1 0.44 ± 0.26 0 0.49 ± 0.28 −0.15 (−0.34 to 0.04) .11
  POD 1 1 0.49 ± 0.31 0 0.54 ± 0.44   
  POD 2 1 0.53 ± 0.33 0 0.48 ± 0.36   
  POD 3 1 0.30 ± 0.30 1 0.45 ± 0.37   
 Any hypotensionc 1 5 (20%) 0 4 (14%) 1.6 (0.4-7.1) .54
 Collapsed composite of postoperative oxygen  
administration, naloxone administration,  
and stopping of local anesthetic infusionc
1 15 (60%) 0 14 (48%) 1.6 (0.6-4.8) .39
Abbreviations: CI, confidence interval, Nmiss, the number of missing; ORSDS, Opioid-Related Symptom Distress Scale; PACU, postanesthesia care unit; POD, 
postoperative day; QL, quadratus lumborum; QoR-15, quality of recovery-15.
aSignificance level for each secondary outcome is P < .01, adjusted for multiple comparisons on 5 outcomes (ie, .05 of 5, Bonferroni correction). Correspondingly, 
99% CIs were reported.
bContinuous outcome summarized as mean ± standard deviation. Estimated difference between QL versus epidural group was estimated from a linear regression 
model. ORSDS is a 4-point scale measured on POD 1–3. The score on each day and the average score over 3 d were summarized as mean ± standard deviation.
cCategorical outcome is summarized as N (%). The estimated odds ratio of having any antiemetic medication was reported as the effect size.
dPatient global assessment, summarized as N (%). P was from Wilcoxon test.
eSignificance level for safety and quality outcomes is P < .05, not adjusted for multiple comparisons.
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